Tenders/Non-Clinical Toxicology and safety assessment of a small molecule

Non-Clinical Toxicology and safety assessment of a small molecule

Helmholtz-Zentrum für Infektionsforschung GmbH

Published: Oct 25, 2026

Updated: Oct 25, 2026

Source: DÖE Bekanntmachungsservice (Germany)

About This Opportunity

This is a consulting contract in the Research and health and medical services sectors, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through DÖE Bekanntmachungsservice (Germany), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for consulting in the Research sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

The overall objective of the present project is to conduct a comprehensive nonclinical toxicology and safety assessment program for a small-molecule drug candidate. The program is intended to characterize the toxicological and safety pharmacology profile of the test item following intravenous infusion and to generate the nonclinical safety data required to support a first-in-human clinical trial and subsequent clinical development. The program shall be conducted in accordance with applicable regulatory requirements and guidelines and shall generate data and documentation suitable for regulatory submissions in the European Union and the United States. Particular attention shall be given to the assessment of renal safety, including the characterization of potential effects of both the test item and the vehicle on renal function and renal toxicity. In addition, the program includes the toxicological assessment of the test item following dermal administration to support the potential clinical evaluation of a semisolid formulation for topical administration. The dermal program is behind a Go/No-Go decision.

Data provenance

This notice is sourced from DÖE Bekanntmachungsservice (Germany) and was originally published on October 25, 2026. Last refreshed today. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Helmholtz-Zentrum für Infektionsforschung GmbH

Helmholtz-Zentrum für Infektionsforschung GmbH has issued 96 procurement notices on BidsFactory, including 3 currently open and 56 awarded contracts. Activity concentrates in Construction & Civil Works, Information & Communication Technology, and General Supplies & Services. All notices are published for Germany. Notices are distributed via DÖE Bekanntmachungsservice (Germany), service.bund.de (Germany), and TED - Tenders Electronic Daily (EU). Most recent publication: October 25, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit DÖE Bekanntmachungsservice (Germany) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Helmholtz-Zentrum für Infektionsforschung GmbH in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Consulting contract in the Research & Innovation sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.